Skin Cancer Research

Skin Cancer Research

Research into skin cancer at Penn State Cancer Institute is conducted by the melanoma and skin cancer team. See current clinical trials and members of that team here.

Clinical Trials

A Phase II Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy or were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
Performance of the DecisionDx-Melanoma Gene Expression Profile Test for Prognosis of Recurrence Risk
Personalized Exercise Oncology (PEXO) - Study
The Collection of Blood, Tissue and Phenotypic Data in Patients Diagnosed with Skin Cancers and Subsequent Metastases for Inclusion in a Repository and Use in Outcome Studies
Atypical Spotzoid Melanocytic Tumors: An Institutional Review of Outcomes for an Effective Treatment
Application for Discarded Tissue From Surgery For Research Use
Definition of Somatic Variants Corresponding to Immune Targets in Patients with Metastatic Melanoma
A Retrospective Evaluation to Understand how â-adrenergic Antagonism Impacts the Progression of Melanoma and the Efficacy of Standard Treatments Intended to Eliminate the Cancer

Disease Team Members

First Name Last Name Title Role
Bryan Anderson, MD Bryan Anderson MD View Researcher Profile
Elizabeth Billingsley, MD Elizabeth Billingsley MD View Researcher Profile
Amanda Cooper, MD Amanda Cooper MD View Researcher Profile
Joseph Drabick, MD, FACP Joseph Drabick MD, FACP View Researcher Profile
Diane Hershock, MD, PhD Diane Hershock MD, PhD View Researcher Profile
Heath Mackley, MD, FACRO Heath Mackley MD, FACRO View Researcher Profile
James Marks, MD James Marks MD View Researcher Profile
Rogerio Neves, MD, PhD Rogerio Neves MD, PhD View Researcher Profile
Colette R. Pameijer, MD Colette R. Pameijer MD View Researcher Profile
Kevin L. Rakszawski, MD Kevin L. Rakszawski MD View Researcher Profile
Marc Rovito, MD Marc Rovito MD View Researcher Profile
Christie Travelute, MD Christie Travelute MD View Researcher Profile
Henry Wagner Jr., MD Henry Wagner Jr. MD View Researcher Profile
Research into skin cancer at Penn State Cancer Institute is conducted by the melanoma and skin cancer team. See current clinical trials and members of that team here.
A Phase II Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy or were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
Performance of the DecisionDx-Melanoma Gene Expression Profile Test for Prognosis of Recurrence Risk
Personalized Exercise Oncology (PEXO) - Study
The Collection of Blood, Tissue and Phenotypic Data in Patients Diagnosed with Skin Cancers and Subsequent Metastases for Inclusion in a Repository and Use in Outcome Studies
Atypical Spotzoid Melanocytic Tumors: An Institutional Review of Outcomes for an Effective Treatment
Application for Discarded Tissue From Surgery For Research Use
Definition of Somatic Variants Corresponding to Immune Targets in Patients with Metastatic Melanoma
A Retrospective Evaluation to Understand how â-adrenergic Antagonism Impacts the Progression of Melanoma and the Efficacy of Standard Treatments Intended to Eliminate the Cancer

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)